Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis

Clinical trial NCT00473460 · COMPLETED

Trial details

NCT number: NCT00473460
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Diseases Bronchitis, Chronic

Start date: 2004-10-01
Primary completion: 2007-01-01
Enrollment: 1404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.